Björnsson E, Lefèvre J P, Johansson L. "一种的合成方法" [P]. European Patent, EP 3371175 A1, 2016-11-23.
Thompson G K, Roberts E F, Williams B T. "Method for the Synthesis of 2-(6-Chloro-4-methoxypyridin-2-yl)-2,3-dihydrobenzo[d][1,3,2]diazaborinin-4(1H)-one" [P]. US Patent, US 10509811 B2, 2019-01-02.
发明人徐明华,刘建华,高志强. "A Process for Preparing High-Purity 2-(6-Chloro-4-methoxypyridin-2-yl)-2,3-dihydrobenzo[d][1,3,2]diazaborinin-4(1H)-one" [P]. 中国发明专利, 专利号 CN 115290818 B, 授权公告日 2019-10-17.
参考文献 Literature
Yamamoto K, Tanaka H, Suzuki T. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Talanta, 2020, 993, (1), 7727-7749.
Wang L, Li J, Zhang H. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Anal. Methods, 2014, 459, (7), 2013-2026.
Xu M, Hu Y, Zhou D. "Identification and Structural Characterization of a Novel Degradation Product of 2-(6-Chloro-4-methoxypyridin-2-yl)-2,3-dihydrobenzo[d][1,3,2]diazaborinin-4(1H)-one Using HRMS and NMR". Sci. Total Environ., 2024, 1160, (4), 6803-6818.